ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
中国生物制药ADR
18.22
0.0000
成交量:
3.00
成交额:
52.72
市值:
165.85亿
市盈率:
34.77
高:
18.22
开:
18.22
低:
18.22
收:
18.22
52周最高:
20.16
52周最低:
7.15
股本:
9.10亿
流通股本:
4.58亿
量比:
0.02
换手率:
NaN%
股息:
0.23
股息率:
1.29%
每股收益(TTM):
0.5241
每股收益(LYR):
0.5242
净资产收益率:
15.40%
总资产收益率:
5.07%
市净率:
3.51
市盈率(LYR):
34.76
数据加载中...
总览
公司
新闻资讯
公告
概念
没有相关数据
资金流向
资金流入:
资金流出:
实时
日
周
月
季度
年
新闻资讯
脱发新药III期成功;创新药出海新模式诞生
药创新
·
昨天
利好密集来袭!创新药概念大爆发
东方财富研究中心
·
10/31
2025年西药行业市场发展现状趋势分析
中研网
·
10/31
中国生物制药又一款 1 类新药首次启动临床
丁香园 Insight 数据库
·
10/30
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/SBHMY"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SBHMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SBHMY\",,,,,undefined,":{"symbol":"SBHMY","market":"US","secType":"STK","nameCN":"中国生物制药ADR","latestPrice":18.22,"timestamp":1764949306151,"preClose":18.22,"halted":0,"volume":3,"delay":15,"floatShares":457950931,"shares":910273459,"eps":0.524054,"marketStatus":"休市中","change":0,"latestTime":"12-05 10:41:46 EST 延时","open":18.22,"high":18.22,"low":18.22,"amount":52.724999999999994,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.524054,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"adrRate":20,"exchange":"PINK LIMITED","adjPreClose":18.22,"volumeRatio":0.023622049104098354},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SBHMY\",,,,,undefined,":{"symbol":"SBHMY","floatShares":457950931,"roa":"5.07%","roe":"15.40%","lyrEps":0.524215,"volumeRatio":0.023622049104098354,"shares":910273459,"dividePrice":0.234789,"high":18.22,"amplitude":0,"preClose":18.22,"low":18.22,"week52Low":7.15,"pbRate":"3.51","psRate":"3.84","week52High":20.16,"institutionHeld":0,"latestPrice":18.22,"eps":0.524054,"divideRate":0.012886,"volume":3,"delay":15,"ttmEps":0.524054,"open":18.22,"prevYearClose":8.335,"prevWeekClose":18.22,"prevMonthClose":18.22,"prevQuarterClose":20.16,"fiveDayClose":18.22,"twentyDayClose":19.445,"sixtyDayClose":20.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SBHMY\",params:#limit:5,,,undefined,":[{"date":"2025-08-29","symbol":"SBHMY","amount":0.127855,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-29","defaultRemindTime":1756474200000,"name":"中国生物制药ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-08","payableDate":"2025-08-29","currency":"USD","dateTimestamp":1756440000000,"payDate":"2025-10-08"},{"date":"2025-06-17","symbol":"SBHMY","amount":0.102066,"announcedDate":"2025-05-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-17","defaultRemindTime":1750167000000,"name":"中国生物制药ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-25","payableDate":"2025-06-17","currency":"USD","dateTimestamp":1750132800000,"payDate":"2025-07-25"},{"date":"2024-09-12","symbol":"SBHMY","amount":0.065379,"announcedDate":"2024-08-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-12","defaultRemindTime":1726147800000,"name":"中国生物制药ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-18","payableDate":"2024-09-12","currency":"USD","dateTimestamp":1726113600000,"payDate":"2024-10-18"},{"date":"2024-09-11","symbol":"SBHMY","amount":0.076916,"announcedDate":"2024-08-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-11","defaultRemindTime":1726061400000,"name":"中国生物制药ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-18","payableDate":"2024-09-11","currency":"USD","dateTimestamp":1726027200000,"payDate":"2024-10-18"},{"date":"2024-06-12","symbol":"SBHMY","amount":0.076829,"announcedDate":"2024-05-29","type":"dividend","market":"US","newRecordDate":"2024-06-12","defaultRemindTime":1718199000000,"name":"中国生物制药ADR","recordDate":"2024-07-22","payableDate":"2024-06-12","currency":"USD","dateTimestamp":1718164800000,"payDate":"2024-07-22"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SBHMY\",market:\"US\",,,undefined,":[{"executeDate":"2018-09-10","recordDate":"2018-09-11","paymentDate":"2018-10-15","value":0.040958,"currency":"USD"},{"executeDate":"2018-12-04","recordDate":"2018-12-05","paymentDate":"2019-01-07","value":0.041124,"currency":"USD"},{"executeDate":"2019-06-13","recordDate":"2019-06-14","paymentDate":"2019-07-19","value":0.040963,"currency":"USD"},{"executeDate":"2019-09-11","recordDate":"2019-09-12","paymentDate":"2019-10-15","value":0.040986,"currency":"USD"},{"executeDate":"2019-12-09","recordDate":"2019-12-10","paymentDate":"2020-01-13","value":0.041103,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SBHMY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.36,"buy":0.6,"hold":0.04,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":25,"updateTime":1758603600000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SBHMY\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2589829615","title":"脱发新药III期成功;创新药出海新模式诞生","url":"https://stock-news.laohu8.com/highlight/detail?id=2589829615","media":"药创新","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589829615?lang=zh_cn&edition=fundamental","pubTime":"2025-12-06 17:01","pubTimestamp":1765011660,"startTime":"0","endTime":"0","summary":"科伦博泰与Crescent达成“双向授权”交易,中国创新药出海再添新玩法;雄激素脱发新药III期临床成功,预计明年申报上市;中国药品价格登记系统上线,面向企业和全球开放查询;默克中国宣布重要任命;FDA再现人事动荡……若Crescent近期发生控制权变更或与第三方签订分许可协议,科伦博泰亦有资格向Crescent收取额外款项。阅读详情>>研发动态雄激素脱发新药III期成功12月4日,Cosmo Pharmaceuticals宣布,Clascoterone用于治疗男性雄激素性脱发的两项关键III期试验中取得积极结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251206170552a437ab11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251206170552a437ab11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SBHMY","BK4134","III"],"gpt_icon":0},{"id":"2579462065","title":"利好密集来袭!创新药概念大爆发","url":"https://stock-news.laohu8.com/highlight/detail?id=2579462065","media":"东方财富研究中心","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579462065?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 17:54","pubTimestamp":1761904444,"startTime":"0","endTime":"0","summary":"据证券时报报道,今年国家医保谈判在延续医保目录常规调整机制的基础上,首次正式引入“商保创新药目录”机制。此外,年内国产创新药“出海”进程明显提速。根据医药魔方NextPharma数据库,截至10月21日,中国创新药今年对外许可共发生115起,金额总计达到1012.4亿美元,远超2024年全年的519亿美元。国信证券指出,中国创新药产业已经体现出长期向好的发展趋势,并在近年集中体现在BD交易的爆发式增长。配置上,看好创新药长期逻辑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031180526a47fc459&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031180526a47fc459&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SBHMY","06990","01952","09995","03759","02552"],"gpt_icon":0},{"id":"2579245144","title":"2025年西药行业市场发展现状趋势分析","url":"https://stock-news.laohu8.com/highlight/detail?id=2579245144","media":"中研网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579245144?lang=zh_cn&edition=fundamental","pubTime":"2025-10-31 17:39","pubTimestamp":1761903584,"startTime":"0","endTime":"0","summary":"2025年西药行业市场发展现状趋势分析在人口老龄化加速、医疗技术革新与政策红利的三重驱动下,中国西药行业正经历从“规模扩张”到“质量跃升”的关键转型。据中研产业研究院《2025-2030年中国西药行业竞争分析及发展前景预测报告》分析二、西药产业链及市场规模1. 上游:原料药国产化与CDMO崛起原料药是西药产业的基石。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031173949a47fb7a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031173949a47fb7a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","LU1046422090.SGD","BK1161","LU0320764599.SGD","01276","01093","09969","06978","BK1141","06160","01801","LU0708995583.HKD","BK1574","03692","SBHMY","BK1576","LU0052750758.USD","LU2125910500.SGD","02359","09995","01177","LU2045819591.USD","LU2242644610.SGD","BK1583"],"gpt_icon":0},{"id":"2579167282","title":"中国生物制药又一款 1 类新药首次启动临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2579167282","media":"丁香园 Insight 数据库","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579167282?lang=zh_cn&edition=fundamental","pubTime":"2025-10-30 14:12","pubTimestamp":1761804767,"startTime":"0","endTime":"0","summary":"10 月 29 日,中国药物临床试验登记与信息公示平台显示,中国生物制药旗下泰德制药1 类新药注射用 TRD208 启动首个临床试验。截图来源:药物临床试验登记与信息公示平台TRD208 是一款非阿片类双模式长效镇痛1 类创新药,融合了神经传导阻滞和抗炎的双重机制,临床前数据显示其对于中度急性疼痛具有显著获益。9 月,该药在国内获批临床,默示许可适应症为成人术后镇痛,并于近日正式启动临床。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251030141540a6d61d5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251030141540a6d61d5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01177","BK1521","BK1191","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","BK1515","IE00BZ08YS42.EUR","BK1589","SBHMY"],"gpt_icon":0}],"pageSize":4,"totalPage":25,"pageCount":1,"totalSize":98,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SBHMY\",params:#limit:6,delay:false,,,undefined,":[]}}